GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS (IST:ONCSM) » Definitions » 10-Year Share Buyback Ratio

Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) 10-Year Share Buyback Ratio : 0.00% (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Oncosem Onkolojik Sistemlernayi ve Ticaret AS 10-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Oncosem Onkolojik Sistemlernayi ve Ticaret AS's current 10-Year Share Buyback Ratio was 0.00%.

IST:ONCSM's 10-Year Share Buyback Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -3.7
* Ranked among companies with meaningful 10-Year Share Buyback Ratio only.

Competitive Comparison of Oncosem Onkolojik Sistemlernayi ve Ticaret AS's 10-Year Share Buyback Ratio

For the Medical Devices subindustry, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's 10-Year Share Buyback Ratio, along with its competitors' market caps and 10-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oncosem Onkolojik Sistemlernayi ve Ticaret AS's 10-Year Share Buyback Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's 10-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Oncosem Onkolojik Sistemlernayi ve Ticaret AS's 10-Year Share Buyback Ratio falls into.


;
;

Oncosem Onkolojik Sistemlernayi ve Ticaret AS 10-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from ten years ago to the current year. The annualized percentage change is calculated with least-square regression based on the eleven years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) 10-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.


Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.


Oncosem Onkolojik Sistemlernayi ve Ticaret AS 10-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Oncosem Onkolojik Sistemlernayi ve Ticaret AS's 10-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Oncosem Onkolojik Sistemlernayi ve Ticaret AS Business Description

Traded in Other Exchanges
N/A
Address
Mutlukent Mah. 1988 Cad. No: 12, Cankaya, Ankara, TUR
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS is specialized in the production of equipment and medical devices used in cancer treatment.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Headlines

No Headlines